Diagnosis and Treatment of Hemifacial Spasm

Diagnostic Considerations

The American College of Radiology recommends using MRI with high-resolution sequences to identify vascular compression of the facial nerve and rule out other causes of facial nerve dysfunction, with 3D heavily T2-weighted MRI sequences and MRA characterizing vascular loops potentially compressing the facial nerve 1, 2, 3
MRI findings of neurovascular contact should be considered supportive rather than diagnostic when selecting candidates for microvascular decompression, according to the American College of Radiology 2

Microvascular decompression has a success rate of approximately 85% and is a microsurgical intervention that addresses the root cause by relieving vascular compression, as reported by the American College of Radiology 1
The American College of Radiology confirms that confirming diagnosis with clinical evaluation and appropriate imaging is the first step in the treatment algorithm 2

Nerve-stabilizing agents, such as pregabalin, gabapentin, and duloxetine, can be prescribed for pain management and spasm control, as recommended by the American Academy of Neurology, with a moderate strength of evidence 4, 5

Patients who cannot tolerate repeated botulinum toxin injections or develop antibodies may be referred for microvascular decompression, according to the American Academy of Otolaryngology-Head and Neck Surgery, with a high strength of evidence 6

Hemifacial spasm as a complication of Bell's palsy requires botulinum toxin injections, not the acute Bell's palsy treatment protocol, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery, with a moderate strength of evidence 6, 7

The American Academy of Neurology supports the use of gabapentin as an alternative oral medication for hemifacial spasm, with a recommended starting dose of 300 mg at bedtime, titrating up to 900-1600 mg daily in divided doses, as reported by the Mayo Clinic Proceedings 8
Pregabalin can be considered as an alternative to gabapentin, with a dosing regimen of 75-300 mg every 12 hours, as reported by the Mayo Clinic Proceedings 8
Baclofen, a GABA-B receptor agonist, is another option with some evidence, and should be tried if gabapentin and pregabalin fail, according to Clinical and Molecular Hepatology 9

Microvascular decompression should be considered for patients who fail botulinum toxin or cannot tolerate repeated injections, with a success rate of approximately 85% and 70% remaining pain-free at 10 years, as reported by the British Journal of Anaesthesia 10
MRI with 3D heavily T2-weighted sequences and MRA should be obtained before surgery to characterize vascular loops compressing the facial nerve, as recommended by the Journal of the American College of Radiology 11
Referral to an experienced neurosurgeon is essential, and complications include 2-4% hearing loss and 0.4% mortality, as reported by the British Journal of Anaesthesia 10

High-resolution MRI is necessary to confirm diagnosis and identify vascular compression, and to rule out secondary causes, as reported by the Journal of the American College of Radiology 11
MRI findings are supportive rather than diagnostic when selecting surgical candidates, and should be used in conjunction with clinical evaluation, as reported by the Journal of the American College of Radiology 11